BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 23562186)

  • 21. Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions.
    Luo J; Zhao X; Tan Z; Su Z; Meng F; Zhang M
    Cytotherapy; 2013 Jun; 15(6):649-62. PubMed ID: 23415919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Fetal Membrane-Derived Mesenchymal Stem Cell Transplantation in Rats With Acute and Chronic Pancreatitis.
    Kawakubo K; Ohnishi S; Fujita H; Kuwatani M; Onishi R; Masamune A; Takeda H; Sakamoto N
    Pancreas; 2016; 45(5):707-13. PubMed ID: 26646279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of allogenic and xenogeneic mesenchymal stem cells on cisplatin-induced acute kidney injury in Sprague-Dawley rats.
    Ashour RH; Saad MA; Sobh MA; Al-Husseiny F; Abouelkheir M; Awad A; Elghannam D; Abdel-Ghaffar H; Sobh M
    Stem Cell Res Ther; 2016 Sep; 7(1):126. PubMed ID: 27585525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury.
    Wise AF; Williams TM; Kiewiet MB; Payne NL; Siatskas C; Samuel CS; Ricardo SD
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1222-35. PubMed ID: 24623144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury.
    Chen Y; Qian H; Zhu W; Zhang X; Yan Y; Ye S; Peng X; Li W; Xu W
    Stem Cells Dev; 2011 Jan; 20(1):103-13. PubMed ID: 20446811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited immune-modulating activity of porcine mesenchymal stromal cells abolishes their protective efficacy in acute kidney injury.
    Brunswig-Spickenheier B; Boche J; Westenfelder C; Peimann F; Gruber AD; Jaquet K; Krause K; Zustin J; Zander AR; Lange C
    Stem Cells Dev; 2010 May; 19(5):719-29. PubMed ID: 20143956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular vesicles from human-induced pluripotent stem cell-derived mesenchymal stromal cells (hiPSC-MSCs) protect against renal ischemia/reperfusion injury via delivering specificity protein (SP1) and transcriptional activating of sphingosine kinase 1 and inhibiting necroptosis.
    Yuan X; Li D; Chen X; Han C; Xu L; Huang T; Dong Z; Zhang M
    Cell Death Dis; 2017 Dec; 8(12):3200. PubMed ID: 29233979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human umbilical cord-derived mesenchymal stromal cells protect against premature renal senescence resulting from oxidative stress in rats with acute kidney injury.
    Rodrigues CE; Capcha JM; de Bragança AC; Sanches TR; Gouveia PQ; de Oliveira PA; Malheiros DM; Volpini RA; Santinho MA; Santana BA; Calado RD; Noronha IL; Andrade L
    Stem Cell Res Ther; 2017 Jan; 8(1):19. PubMed ID: 28129785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra-renal arterial injection of autologous bone marrow mesenchymal stromal cells ameliorates cisplatin-induced acute kidney injury in a rhesus Macaque mulatta monkey model.
    Moghadasali R; Azarnia M; Hajinasrollah M; Arghani H; Nassiri SM; Molazem M; Vosough A; Mohitmafi S; Najarasl M; Ajdari Z; Yazdi RS; Bagheri M; Ghanaati H; Rafiei B; Gheisari Y; Baharvand H; Aghdami N
    Cytotherapy; 2014 Jun; 16(6):734-49. PubMed ID: 24801377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of mesenchymal stem cells in the functional improvement of chronic renal failure.
    Choi S; Park M; Kim J; Hwang S; Park S; Lee Y
    Stem Cells Dev; 2009 Apr; 18(3):521-9. PubMed ID: 18647091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury.
    Zilberman-Itskovich S; Abu-Hamad R; Zarura R; Sova M; Hachmo Y; Stark M; Neuman S; Slavin S; Efrati S
    PLoS One; 2019; 14(9):e0222354. PubMed ID: 31513644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adipose-derived mesenchymal stem cells therapy for acute kidney injury induced by ischemia-reperfusion in a rat model.
    Zhang JB; Wang XQ; Lu GL; Huang HS; Xu SY
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1232-1240. PubMed ID: 28688148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model.
    He J; Wang Y; Sun S; Yu M; Wang C; Pei X; Zhu B; Wu J; Zhao W
    Nephrology (Carlton); 2012 Jul; 17(5):493-500. PubMed ID: 22369283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms.
    Tögel F; Hu Z; Weiss K; Isaac J; Lange C; Westenfelder C
    Am J Physiol Renal Physiol; 2005 Jul; 289(1):F31-42. PubMed ID: 15713913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury.
    Gao J; Liu R; Wu J; Liu Z; Li J; Zhou J; Hao T; Wang Y; Du Z; Duan C; Wang C
    Biomaterials; 2012 May; 33(14):3673-81. PubMed ID: 22361096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy.
    Tseng WC; Lee PY; Tsai MT; Chang FP; Chen NJ; Chien CT; Hung SC; Tarng DC
    Stem Cell Res Ther; 2021 Jun; 12(1):367. PubMed ID: 34183058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mesenchymal stem cells attenuate acute kidney injury via regulation of natural immune system].
    Hu J; Zhang L; Cui S; Zhu F; Li D; Feng Z; Chen X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):235-40. PubMed ID: 29917337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced pluripotent stem cells without c-Myc attenuate acute kidney injury via downregulating the signaling of oxidative stress and inflammation in ischemia-reperfusion rats.
    Lee PY; Chien Y; Chiou GY; Lin CH; Chiou CH; Tarng DC
    Cell Transplant; 2012; 21(12):2569-85. PubMed ID: 22507855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic potential of mesenchymal stem cells in acute kidney injury is affected by administration timing.
    Liu X; Cai J; Jiao X; Yu X; Ding X
    Acta Biochim Biophys Sin (Shanghai); 2017 Apr; 49(4):338-348. PubMed ID: 28338909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia.
    Hara Y; Stolk M; Ringe J; Dehne T; Ladhoff J; Kotsch K; Reutzel-Selke A; Reinke P; Volk HD; Seifert M
    Transpl Int; 2011 Nov; 24(11):1112-23. PubMed ID: 21880071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.